Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

GLP1-RAs may have higher reports of suicidal events and hair loss compared to other diabetes drugs.

Young Indians with coronary artery disease often have risk factors like smoking and central obesity, and cutaneous markers should be monitored for lifestyle changes.

Lisinopril improves heart health more in men with normal hair than those with early hair loss.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Minoxidil doesn't increase pericardial disorder risk, but may cause fluid accumulation.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

Cardiovascular drugs can cause various skin problems, so recognizing these reactions is important.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

Male-pattern baldness is weakly linked to some heart disease risk factors but not a strong indicator for heart disease.

Migrants from certain regions had a higher risk of COVID-19 than Spaniards.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

Women with PCOS are at higher risk for gum disease, and managing shared risk factors can help both conditions.

Bald men may have higher heart disease risk.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Premature hair greying may indicate a higher risk of metabolic problems.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Baldness may indicate higher heart disease risk in men.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

People with alopecia areata have a higher risk of stroke.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Physical activity, height, and smoking affect prostate cancer risk.